首页 > 市场调查报告书 > 製药

感染疾病

市场调查报告书

商品编码

1460170

抗菌药物抗药性监测市场规模 - 按解决方案（诊断套件、系统和软体）、应用（公共卫生监测、实验室监测、临床诊断）、最终用途（医院、诊所）和预测，2024 - 2032 年

Antimicrobial Resistance Surveillance Market Size - By Solution (Diagnostic Kits, Systems, & Software), Application (Public Health Surveillance, Laboratory Surveillance, Clinical Diagnostics), End-use (Hospitals, Clinics) & Forecast, 2024 - 2032

出版日期: 2024年02月29日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在医疗保健组织、研究机构和政府机构之间的合作努力的推动下，抗菌药物抗药性监测市场规模预计从 2024 年到 2032 年将以 5.8% 的CAGR扩大。

不断增加的伙伴关係正在促进监测技术的创新，从而能够开发用于检测和追踪抗药性病原体的先进工具。例如，2023 年 6 月，加拿大公共卫生局国家微生物实验室 (NML) 的几位研究人员调查了加拿大抗菌素抗药性的流行情况。认识到需要一个可以捕获全国各地资料的网络，NML 创建了抗菌素抗药性网络(AMRNet)，这是一个基于实验室的监测系统，用于收集临床和兽医实验室中AMR 测试的细菌和真菌样本的资料。此类合作措施汇集资源、专业知识和资料，以增强监测能力，从而製定更有效的抗菌药物抗药性控制策略，从而扩大市场前景。

整个产业分为解决方案、应用、最终用途和区域。

在解决方案方面，诊断软体领域的抗菌药物抗药性监测市场预计从 2024 年到 2032 年将成长 6.3%。用于抗菌药物抗药性监测的先进软体解决方案提供即时监测、资料分析和趋势识别，帮助医疗机构制定有效的决策和感染控制措施。它们还可以快速识别抗药性病原体，以便及时采取干预措施和治疗策略。此外，人工智慧和机器学习演算法的整合提高了监控系统的准确性和效率，进一步促进了该细分市场的成长。

根据应用情况，公共卫生监测领域的抗菌药物抗药性监测产业在 2023 年产生了可观的收入，预计 2024 年至 2032 年CAGR为6.1%。世界各地的公共卫生机构依靠先进的监测系统来监测和追踪抗药性的传播抗菌素抗药性。加强监测能够及时采取干预措施、制定政策和有针对性的干预措施，以在更广泛的范围内对抗抗菌素抗药性。随着人们越来越关注防止抗药性病原体的传播和改善患者的治疗结果，对强大的公共卫生监测解决方案的需求将会增加。

从地区来看，亚太地区抗菌药物抗药性监测产业预计在 2024 年至 2032 年期间CAGR为 6.3%。人口众多且多样化，加上医疗保健支出不断增加，刺激了该地区对有效监测解决方案的需求。政府采取了多项旨在控制传染病和改善医疗基础设施的措施。此外，抗菌药物抗药性病原体的日益普及正在推动先进监测技术的采用，从而扩大区域产业前景。

产业生态系统分析
产业影响力
- 成长动力
  - 抗菌药物抗药性发生率上升
  - 传染病流行率不断上升
  - 提高认识和筛检计划
  - 诊断技术的进步
- 产业陷阱与挑战
  - 与程序相关的高成本
  - 缺乏标准化协议
成长潜力分析
监管环境
技术景观
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按解决方案，2018 年 - 2032 年

主要趋势
诊断试剂盒
诊断系统
诊断软体
服务

第 6 章：市场估计与预测：按应用分类，2018 年 - 2032 年

主要趋势
公共卫生监测
实验室监测
临床诊断
其他应用

第 7 章：市场估计与预测：按最终用途，2018 - 2032 年

主要趋势
医院
诊所
研究与学术机构
其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Abbott Laboratories
Accelerate Diagnostics, Inc.
Becton, Dickinson and Company (BD)
Biomereiux SA
Bruker Corporation
Himedia Laboratories Pvt. Ltd.
Opgen Inc.
Danaher Corporation
Luminex Corporation
Merck & Co., Inc.
Thermo Fisher Scientific Inc.

简介目录

Product Code: 8340

Antimicrobial Resistance Surveillance Market size is projected to expand at 5.8% CAGR from 2024 to 2032 driven by the collaborative efforts among healthcare organizations, research institutions, and government bodies.

Increasing partnerships are fostering innovations in surveillance technologies, enabling the development of advanced tools for detecting and tracking resistant pathogens. For instance, in June 2023, several researchers at the Public Health Agency of Canada's National Microbiology Laboratory (NML) investigated the prevalence of antimicrobial resistance in Canada. Recognizing the need for a network that could capture data from across the nation, the NML created the Antimicrobial Resistance Network, or AMRNet, a lab-based monitoring system to collect data from bacterial and fungal samples tested for AMR in clinical and veterinary labs. Such collaborative initiatives pool resources, expertise, and data to enhance surveillance capabilities, leading to more effective strategies for antimicrobial resistance control, thereby augmenting the market outlook.

The overall industry is segmented into solution, application, end-use, and region.

In terms of solution, the antimicrobial resistance surveillance market from the diagnostic software segment is anticipated to witness 6.3% growth rate from 2024-2032. Advanced software solutions for antimicrobial resistance surveillance offer real-time monitoring, data analysis, and trend identification, aiding healthcare facilities in effective decision-making and infection control measures. They also provide rapid identification of resistant pathogens for enabling timely interventions and treatment strategies. Moreover, the integration of AI and ML algorithms enhances the accuracy and efficiency of surveillance systems, further adding to the segment growth.

Based on application, the antimicrobial resistance surveillance industry from the public health surveillance segment generated considerable revenue in 2023 and is estimated to depict a 6.1% CAGR between 2024 and 2032. Public health agencies worldwide rely on advanced surveillance systems to monitor and track the spread of antimicrobial resistance. Enhanced surveillance enables timely interventions, policy developments, and targeted interventions to combat antimicrobial resistance on a broader scale. With the increasing focus on preventing the spread of resistant pathogens and improving patient outcomes, the demand for robust public health surveillance solutions will rise.

Regionally, the Asia Pacific antimicrobial resistance surveillance industry is set to exhibit 6.3% CAGR during 2024-2032. The large and diverse population coupled with the rising healthcare expenditure are fueling the demand for effective surveillance solutions in the region. There are several government initiatives aimed at controlling infectious diseases and improving healthcare infrastructure. Additionally, the increasing prevalence of antimicrobial-resistant pathogens is driving the adoption of advanced surveillance technologies, thereby augmenting the regional industry outlook.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of antimicrobial resistance
  - 3.2.1.2 Increasing prevalence of infectious diseases
  - 3.2.1.3 Rising awareness and screening programs
  - 3.2.1.4 Advancements in diagnostic technologies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with the procedures
  - 3.2.2.2 Lack of standardized protocols
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Solution, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Diagnostic kits
5.3 Diagnostic systems
5.4 Diagnostic software
5.5 Services

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Public health surveillance
6.3 Laboratory surveillance
6.4 Clinical diagnostics
6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Research & academic institutes
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa